Abstract
Effective pharmacotherapy is a valuable tool to treat addiction disorders. It has included partial μ agonist, such as buprenorphine, and μ opioid agonists, such as methadone. The pharmacological basis of maintenance treatment of dependent individuals is to minimize withdrawal symptoms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949–58.
Maxwell JC, McCance-Katz EF. Indicators of buprenorphine and methadone use and abuse: what do we know? Am J Addict. 2010;19:73–88.
Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Co-chrane Database Syst Rev. 2003;3:CD002208.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Imani, F. (2019). Pharmacologic Treatment of Patients with Addiction. In: Abd-Elsayed, A. (eds) Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-99124-5_243
Download citation
DOI: https://doi.org/10.1007/978-3-319-99124-5_243
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99123-8
Online ISBN: 978-3-319-99124-5
eBook Packages: MedicineMedicine (R0)